Phase 1/2 Trial Evaluating AOC 1044 in Healthy Volunteers and Participants with DMD Mutations Amenable to Exon 44 Skipping (DMD44): EXPLORE44 Trial Design (P4-8.007)

To evaluate the safety and tolerability of single and multiple ascending doses of AOC 1044 in healthy volunteers and participants with DMD44